Physician profile
Ryan Eric Kern
NPI 1497232425
$7,551.80
in general payments reported to CMS, 2019-2025
17 companies · $563 in 2025
The $563 reported for 2025 was more than what 80% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $506 · 2020: $52.63 · 2021: $114 · 2022: $1,035 · 2023: $5,282 · 2025: $563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,844.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,844.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $6,100.62 | 2022-2023 | Optilight |
| Alcon Vision LLC | $381.53 | 2019-2025 | Tryptyr, Rocklatan |
| Bausch & Lomb Americas INC. | $248.40 | 2025 | Xiidra, Miebo, Infuse |
| Apellis Pharmaceuticals, INC. | $144.90 | 2023 | Syfovre |
| Sun Pharmaceutical Industries INC. | $132.19 | 2021-2025 | |
| Johnson & Johnson Vision Care, INC. | $121.55 | 2019 | |
| Coopervision INC. | $109.36 | 2019 | |
| Shire North American Group INC | $106.68 | 2019 | |
| Lombart Brothers, INC. | $52.63 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $24.32 | 2025 | Xdemvy |
| Inspire Medical Systems, INC. | $22.56 | 2023 | Inspire |
| Novartis Pharmaceuticals Corporation | $21.36 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $20.27 | 2019 | |
| Oyster Point Pharma, INC. | $18.65 | 2022 | |
| Spark Therapeutics, INC. | $17.18 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $16.17 | 2022 | |
| Horizon Therapeutics Plc | $13.43 | 2023 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Kern listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.